Emil Frei

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

I. Craig Henderson, Donald A. Berry, George D. Demetri et al. · Journal of Clinical Oncology · 2003 · 1.3K citations

Medicine, Oncology, Pharmacology +17

A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer

Robert O. Dillman, Stephen L. Seagren, Kathleen J. Propert et al. · New England Journal of Medicine · 1990 · 1.2K citations · Full text

Medicine, Oncology, Radiation Oncology +12

Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide

C. Gordon Zubrod, Marvin A. Schneiderman, Emil Frei et al. · Journal of Chronic Diseases · 1960 · 1K citations

Medicine, Oncology, Chemotherapy +4

Dose: A critical factor in cancer chemotherapy

Emil Frei, George P. Canellos · The American Journal of Medicine · 1980 · 848 citations

Medicine, Oncology, Pharmacology +14

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced Myelosuppression

Karen Antman, James D. Griffin, Anthony Elias et al. · New England Journal of Medicine · 1988 · 684 citations

Medicine, Hematology, Oncology +17